(Q34550618)

English

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

2

object named as

Siegfried Kasper

0 references

object named as

Heinz Grunze

1

0 references

Hans-Jürgen Möller

5

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Guy Goodwin

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Charles Bowden

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

WFSBP Task Force on Treatment Guidelines for Bipolar Disorders

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

120-135

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Switch from depression to mania--a record study over decades between 1920 and 1982.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A new bipolar spectrum concept: a brief review

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Maintenance therapies for classic and other forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinical studies on the use of lamotrigine in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The enduring psychosocial consequences of mania and depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Outcome in the pharmacologic treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Recurrence in affective disorder. I. Case register study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Rapid recurrence of mania following abrupt discontinuation of lithium

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Expanding the group of bipolar disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium-discontinuation-induced refractoriness: preliminary observations.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A review of continuation and maintenance electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Bipolar II disorder and suicidal behavior

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Response to maintenance therapy in bipolar illness. Effect of index episode.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Discontinuation of maintenance treatment in bipolar disorder: risks and implications

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lamotrigine for the treatment of bipolar disorder: a clinical case series.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus divalproex in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium use and discontinuation in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Suicidal Behavior in Bipolar I and Bipolar II Disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Differential features between bipolar I and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Identifiers

10.1080/15622970410029924

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34550618&oldid=1714004394"